Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC).

Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SL.

Ann Surg Oncol. 2019 Oct 17. doi: 10.1245/s10434-019-07807-9. [Epub ahead of print]

PMID:
31625045
2.

Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.

Matsushita T, Sekizawa A, Jacobs LK.

J Minim Invasive Gynecol. 2019 Mar 30. pii: S1553-4650(19)30144-X. doi: 10.1016/j.jmig.2019.03.019. [Epub ahead of print]

PMID:
30936031
3.

Surgeon Re-Excision Rates after Breast-Conserving Surgery: A Measure of Low-Value Care.

Kaczmarski K, Wang P, Gilmore R, Overton HN, Euhus DM, Jacobs LK, Habibi M, Camp M, Weiss MJ, Makary MA.

J Am Coll Surg. 2019 Apr;228(4):504-512.e2. doi: 10.1016/j.jamcollsurg.2018.12.043. Epub 2019 Jan 29.

PMID:
30703538
4.

Interpretation of Optical Coherence Tomography Images for Breast Tissue Assessment.

Yemul KS, Zysk AM, Richardson AL, Tangella KV, Jacobs LK.

Surg Innov. 2019 Feb;26(1):50-56. doi: 10.1177/1553350618803245. Epub 2018 Oct 7.

PMID:
30295149
5.

Ductal Carcinoma In Situ.

Fu F, Gilmore RC, Jacobs LK.

Surg Clin North Am. 2018 Aug;98(4):725-745. doi: 10.1016/j.suc.2018.03.007. Epub 2018 May 28. Review.

PMID:
30005770
6.

Tumor Site and Breast Cancer Prognosis.

Siotos C, McColl M, Psoter K, Gilmore RC, Sebai ME, Broderick KP, Jacobs LK, Irwin S, Rosson GD, Habibi M.

Clin Breast Cancer. 2018 Oct;18(5):e1045-e1052. doi: 10.1016/j.clbc.2018.05.007. Epub 2018 May 29.

PMID:
29941391
7.

Oncoplastic Breast Reconstruction: Should All Patients be Considered?

Habibi M, Broderick KP, Sebai ME, Jacobs LK.

Surg Oncol Clin N Am. 2018 Jan;27(1):167-180. doi: 10.1016/j.soc.2017.07.007. Review.

PMID:
29132559
8.

The site of care matters: An examination of the relationship between high Medicaid burden hospitals and the use, cost, and complications of immediate breast reconstruction after mastectomy.

Offodile AC 2nd, Muldoon LD, Gani F, Canner JK, Jacobs LK.

Cancer. 2018 Jan 15;124(2):346-355. doi: 10.1002/cncr.31046. Epub 2017 Oct 17.

9.

Beyond the Margins-Economic Costs and Complications Associated With Repeated Breast-Conserving Surgeries.

Metcalfe LN, Zysk AM, Yemul KS, Jacobs LK, Oker EE, Underwood HR, Thompson AM.

JAMA Surg. 2017 Nov 1;152(11):1084-1086. doi: 10.1001/jamasurg.2017.2661. No abstract available.

10.

Quality-of-Life Outcomes Improve with Nipple-Sparing Mastectomy and Breast Reconstruction.

Bailey CR, Ogbuagu O, Baltodano PA, Simjee UF, Manahan MA, Cooney DS, Jacobs LK, Tsangaris TN, Cooney CM, Rosson GD.

Plast Reconstr Surg. 2017 Aug;140(2):219-226. doi: 10.1097/PRS.0000000000003505.

PMID:
28746266
11.

Axillary Lymphadenectomy in Sentinel Lymph Node-Positive Breast Cancer.

Zhu L, Chen K, Jacobs LK, Aft R.

Ann Surg Oncol. 2018 Jan;25(1):28-31. doi: 10.1245/s10434-017-5849-8. Epub 2017 Mar 31. No abstract available.

PMID:
28364290
12.

Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.

Liu J, Chen K, Jiang W, Mao K, Li S, Kim MJ, Liu Q, Jacobs LK.

J Cancer Res Clin Oncol. 2017 Jan;143(1):161-168. doi: 10.1007/s00432-016-2281-6. Epub 2016 Oct 4.

PMID:
27704268
13.

Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.

Stearns V, Fackler MJ, Hafeez S, Bujanda ZL, Chatterton RT, Jacobs LK, Khouri NF, Ivancic D, Kenney K, Shehata C, Jeter SC, Wolfman JA, Zalles CM, Huang P, Khan SA, Sukumar S.

Cancer Prev Res (Phila). 2016 Aug;9(8):673-682. doi: 10.1158/1940-6207.CAPR-15-0377. Epub 2016 Jun 3.

14.

Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.

King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, Sing AP, Hwang ES, Alvarado MD, Liu MC, Boughey JC, McGuire KP, Van Poznak CH, Jacobs LK, Meszoely IM, Krontiras H, Babiera GV, Norton L, Morrow M, Hudis CA.

J Clin Oncol. 2016 Jul 10;34(20):2359-65. doi: 10.1200/JCO.2015.63.1960. Epub 2016 Mar 21.

15.
16.

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis.

Chen K, Liu J, Zhu L, Su F, Song E, Jacobs LK.

Oncotarget. 2015 Nov 24;6(37):40127-40. doi: 10.18632/oncotarget.5394.

17.

The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis.

Liu J, Chen K, Mao K, Su F, Liu Q, Jacobs LK.

Oncotarget. 2016 Feb 2;7(5):6063-73. doi: 10.18632/oncotarget.5844.

18.

Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, Jacobs LK, Xiao Z, Wang J.

J Gastroenterol Hepatol. 2016 Feb;31(2):417-26. doi: 10.1111/jgh.13072.

19.

Intraoperative Assessment of Final Margins with a Handheld Optical Imaging Probe During Breast-Conserving Surgery May Reduce the Reoperation Rate: Results of a Multicenter Study.

Zysk AM, Chen K, Gabrielson E, Tafra L, May Gonzalez EA, Canner JK, Schneider EB, Cittadine AJ, Scott Carney P, Boppart SA, Tsuchiya K, Sawyer K, Jacobs LK.

Ann Surg Oncol. 2015 Oct;22(10):3356-62. doi: 10.1245/s10434-015-4665-2. Epub 2015 Jul 23.

20.

Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.

Liu J, Jiang W, Mao K, An Y, Su F, Kim BY, Liu Q, Jacobs LK.

Breast Cancer Res Treat. 2015 Apr;150(2):439-45. doi: 10.1007/s10549-015-3315-5. Epub 2015 Mar 13.

21.

A Nomogram to Predict the Benefit of Radiation Therapy After Breast-Conserving Surgery in Elderly Patients with Stage I & ER-Negative, or Stage II/III Disease.

Chen K, Su F, Jacobs LK.

Ann Surg Oncol. 2015 Oct;22(11):3497-503. doi: 10.1245/s10434-015-4393-7. Epub 2015 Feb 10.

PMID:
25665951
22.

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.

Connolly RM, Leal JP, Goetz MP, Zhang Z, Zhou XC, Jacobs LK, Mhlanga J, O JH, Carpenter J, Storniolo AM, Watkins S, Fetting JH, Miller RS, Sideras K, Jeter SC, Walsh B, Powers P, Zorzi J, Boughey JC, Davidson NE, Carey LA, Wolff AC, Khouri N, Gabrielson E, Wahl RL, Stearns V.

J Nucl Med. 2015 Jan;56(1):31-7. doi: 10.2967/jnumed.114.144741. Epub 2014 Dec 4.

23.

Risk of severe and refractory postoperative nausea and vomiting in patients undergoing diep flap breast reconstruction.

Manahan MA, Basdag B, Kalmar CL, Shridharani SM, Magarakis M, Jacobs LK, Thomsen RW, Rosson GD.

Microsurgery. 2014 Feb;34(2):112-21. doi: 10.1002/micr.22155. Epub 2013 Aug 28.

24.

Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.

Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, Espinoza-Delgado I, Sukumar S, Gabrielson E, Davidson NE.

Clin Cancer Res. 2013 Jul 15;19(14):4008-16. doi: 10.1158/1078-0432.CCR-13-0033. Epub 2013 May 29.

25.

Collagen I fiber density increases in lymph node positive breast cancers: pilot study.

Kakkad SM, Solaiyappan M, Argani P, Sukumar S, Jacobs LK, Leibfritz D, Bhujwalla ZM, Glunde K.

J Biomed Opt. 2012 Nov;17(11):116017. doi: 10.1117/1.JBO.17.11.116017.

26.

Lymphedema: still a problem without an answer.

Hardin R, Jacobs LK.

Oncology (Williston Park). 2012 Mar;26(3):256-7. No abstract available.

27.

Paget's disease: a potential predictor of breast cancer survival?

Jacobs LK, Hardin RE.

Arch Surg. 2011 Nov;146(11):1271. No abstract available.

PMID:
22213846
28.

Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.

Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, Tsangaris TN, Sukumar S.

Sci Transl Med. 2011 Oct 26;3(106):106ra108. doi: 10.1126/scitranslmed.3002368.

29.

Merkel cell carcinoma: update and review.

Wang TS, Byrne PJ, Jacobs LK, Taube JM.

Semin Cutan Med Surg. 2011 Mar;30(1):48-56. doi: 10.1016/j.sder.2011.02.001. Review.

30.

A review of the surgical management of breast cancer: plastic reconstructive techniques and timing implications.

Rosson GD, Magarakis M, Shridharani SM, Stapleton SM, Jacobs LK, Manahan MA, Flores JI.

Ann Surg Oncol. 2010 Jul;17(7):1890-900. doi: 10.1245/s10434-010-0913-7. Epub 2010 Mar 9. Review.

PMID:
20217253
31.

Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.

Chumsri S, Jeter S, Jacobs LK, Nassar H, Armstrong DK, Emens LA, Fetting JH, Lange JR, Riley C, Tsangaris TN, Wolff AC, Zellars R, Zhang Z, Stearns V.

Clin Breast Cancer. 2010 Feb;10(1):40-5. doi: 10.3816/CBC.2010.n.005.

PMID:
20133257
32.

Predicting the risk of axillary nodal metastases and their use in selecting breast surgery options.

Jacobs LK, Balch CM, Soong SJ.

J Clin Oncol. 2009 Dec 1;27(34):5673-5. doi: 10.1200/JCO.2009.24.4525. Epub 2009 Oct 13. No abstract available.

PMID:
19826107
33.

Mastectomies on the rise for breast cancer: "the tide is changing".

Balch CM, Jacobs LK.

Ann Surg Oncol. 2009 Oct;16(10):2669-72. doi: 10.1245/s10434-009-0634-y. Epub 2009 Jul 31. No abstract available.

34.

Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.

Zellars RC, Stearns V, Frassica D, Asrari F, Tsangaris T, Myers L, DiPasquale S, Lange JR, Jacobs LK, Emens LA, Armstrong DK, Fetting JH, Garrett-Mayer E, Davidson NE, Wolff AC.

J Clin Oncol. 2009 Jun 10;27(17):2816-22. doi: 10.1200/JCO.2008.20.0139. Epub 2009 Mar 30.

35.

Multilevel analysis of the impact of community vs patient factors on access to immediate breast reconstruction following mastectomy in Maryland.

Rosson GD, Singh NK, Ahuja N, Jacobs LK, Chang DC.

Arch Surg. 2008 Nov;143(11):1076-81; discusion 1081. doi: 10.1001/archsurg.143.11.1076.

PMID:
19015466
36.

Nipple-sparing mastectomy: critical assessment of 51 procedures and implications for selection criteria.

Voltura AM, Tsangaris TN, Rosson GD, Jacobs LK, Flores JI, Singh NK, Argani P, Balch CM.

Ann Surg Oncol. 2008 Dec;15(12):3396-401. doi: 10.1245/s10434-008-0102-0. Epub 2008 Oct 16.

PMID:
18923874
37.

Disparities in urban and rural mastectomy populations : the effects of patient- and county-level factors on likelihood of receipt of mastectomy.

Jacobs LK, Kelley KA, Rosson GD, Detrani ME, Chang DC.

Ann Surg Oncol. 2008 Oct;15(10):2644-52. doi: 10.1245/s10434-008-0053-5. Epub 2008 Jul 29.

PMID:
18663535
38.

Sorting through the heterogeneity of recurrent melanoma.

Jacobs LK, Lange JR, Balch CM.

Ann Surg Oncol. 2008 May;15(5):1280-1. doi: 10.1245/s10434-008-9823-3. Epub 2008 Mar 5. No abstract available.

39.

The role of ultrasound-guided fine-needle aspiration of axillary nodes in the staging of breast cancer.

Jain A, Haisfield-Wolfe ME, Lange J, Ahuja N, Khouri N, Tsangaris T, Zhang Z, Balch C, Jacobs LK.

Ann Surg Oncol. 2008 Feb;15(2):462-71. Epub 2007 Nov 6.

PMID:
17985188
40.

Can a small nodal metastasis reliably alter intraoperative risk/benefit decision making in breast cancer surgery?

Jacobs LK, Balch C.

Ann Surg Oncol. 2007 Nov;14(11):3040-2. Epub 2007 Sep 19. No abstract available.

PMID:
17879118
41.

Lumpectomy or mastectomy: is quality of life the tie-breaker?

Jacobs LK.

Ann Surg Oncol. 2007 Nov;14(11):3035-6. Epub 2007 Sep 1. No abstract available.

PMID:
17763910
42.

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.

Lymphology. 2004 Jun;37(2):73-91.

PMID:
15328760
43.

Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.

Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, Kennedy KA, Patierno SR.

Breast Cancer Res Treat. 2000 Jan;59(1):15-26.

PMID:
10752676
44.

Endoscopic axillary exploration and sentinel lymphadenectomy.

Tsangaris TN, Trad K, Brody FJ, Jacobs LK, Tsangaris NT, Sackier JM.

Surg Endosc. 1999 Jan;13(1):43-7.

PMID:
9869687
45.

Intraabdominal adhesion formation after preperitoneal dissection in the murine model.

Halverson AL, Barrett WL, Bhanot P, Phillips JE, Iglesias AR, Jacobs LK, Sackier JM.

Surg Endosc. 1999 Jan;13(1):14-6.

PMID:
9869680
46.

Common bile duct T-tubes. A caveat and recommendations for management.

Jacobs LK, Shayani V, Sackier JM.

Surg Endosc. 1998 Jan;12(1):60-2.

PMID:
9419307
47.

The best operation for rectal prolapse.

Jacobs LK, Lin YJ, Orkin BA.

Surg Clin North Am. 1997 Feb;77(1):49-70. Review.

PMID:
9092117
48.

Determination of the learning curve of the AESOP robot.

Jacobs LK, Shayani V, Sackier JM.

Surg Endosc. 1997 Jan;11(1):54-5.

PMID:
8994989
49.

Laparoscopic colectomy.

Sackier JM, Jacobs LK.

Dis Colon Rectum. 1996 Apr;39(4):473. No abstract available.

PMID:
8878512

Supplemental Content

Loading ...
Support Center